Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing. more
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | 0.97% | 0.01% |
| 1-Month Return | 18.47% | 3.54% |
| 3-Month Return | 18.97% | 10.58% |
| 6-Month Return | 24.41% | 8.03% |
| 1-Year Return | 60.32% | 20.06% |
| 3-Year Return | 90.09% | 70.98% |
| 5-Year Return | 91.55% | 71.89% |
| 10-Year Return | 249.34% | 252.66% |
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | 65.43% | 0.52% |
| 1-Month Return | 686.26% | 52.69% |
| 3-Month Return | 102.27% | 50.36% |
| 6-Month Return | 55.72% | 16.96% |
| 1-Year Return | 60.32% | 20.06% |
| 3-Year Return | 23.88% | 19.58% |
| 5-Year Return | 13.88% | 11.44% |
| 10-Year Return | 13.32% | 13.43% |
| Stock name | Ticker | Weight |
|---|---|---|
Crinetics Pharmaceuticals Inc
|
CRNX |
3.03%
|
Moderna Inc
|
MRNA |
1.91%
|
Agios Pharmaceuticals Inc
|
AGIO |
1.81%
|
Ultragenyx Pharmaceutical Inc
|
RARE |
1.77%
|
Syndax Pharmaceuticals Inc
|
SNDX |
1.7%
|
Geron Corp
|
GERN |
1.69%
|
Bridgebio Pharma Inc
|
BBIO |
1.68%
|
Sarepta Therapeutics Inc
|
SRPT |
1.67%
|
Kura Oncology Inc
|
KURA |
1.67%
|
Rigel Pharmaceuticals Inc
|
RIGL |
1.66%
|
Verastem Inc
|
VSTM |
1.64%
|
Rhythm Pharmaceuticals Inc
|
RYTM |
1.63%
|
Mirum Pharmaceuticals Inc
|
MIRM |
1.6%
|
Ironwood Pharmaceuticals Inc
|
IRWD |
1.6%
|
Xeris Biopharma Holdings Inc
|
XERS |
1.58%
|
Ascendis Pharma A/S
|
ASND |
1.58%
|
Ligand Pharmaceuticals Inc
|
LGND |
1.58%
|
Kiniksa Pharmaceuticals International Plc
|
KNSA |
1.57%
|
Denali Therapeutics Inc
|
DNLI |
1.57%
|
Protagonist Therapeutics Inc
|
PTGX |
1.57%
|
ACADIA Pharmaceuticals Inc
|
ACAD |
1.56%
|
ImmunityBio Inc
|
IBRX |
1.56%
|
Precigen Inc
|
PGEN |
1.55%
|
Nuvation Bio Inc
|
NUVB |
1.55%
|
BioCryst Pharmaceuticals Inc
|
BCRX |
1.54%
|
Cytokinetics Inc
|
CYTK |
1.53%
|
Roivant Sciences Ltd
|
ROIV |
1.53%
|
Insmed Inc
|
INSM |
1.51%
|
TG Therapeutics Inc
|
TGTX |
1.49%
|
PTC Therapeutics Inc
|
PTCT |
1.49%
|
Zymeworks Inc
|
ZYME |
1.48%
|
Arcutis Biotherapeutics Inc
|
ARQT |
1.47%
|
Omeros Corp
|
OMER |
1.47%
|
Phathom Pharmaceuticals Inc
|
PHAT |
1.46%
|
Zai Lab Ltd
|
ZLAB |
1.46%
|
Krystal Biotech Inc
|
KRYS |
1.46%
|
Madrigal Pharmaceuticals Inc
|
MDGL |
1.45%
|
BeOne Medicines Ltd
|
BGNE |
1.43%
|
Liquidia Corp
|
LQDA |
1.43%
|
Immunocore Holdings PLC
|
IMCR |
1.43%
|
CRISPR Therapeutics AG
|
CRSP |
1.41%
|
Halozyme Therapeutics Inc
|
HALO |
1.41%
|
Neurocrine Biosciences Inc
|
NBIX |
1.41%
|
ADMA Biologics Inc
|
ADMA |
1.41%
|
Arrowhead Pharmaceuticals Inc
|
ARWR |
1.41%
|
Travere Therapeutics Inc
|
TVTX |
1.4%
|
Vertex Pharmaceuticals Inc
|
VRTX |
1.39%
|
Harmony Biosciences Holdings Inc
|
HRMY |
1.38%
|
Alnylam Pharmaceuticals Inc
|
ALNY |
1.38%
|
Incyte Corp
|
INCY |
1.36%
|
Regeneron Pharmaceuticals Inc
|
REGN |
1.36%
|
Exelixis Inc
|
EXEL |
1.34%
|
Gilead Sciences Inc
|
GILD |
1.34%
|
BioMarin Pharmaceutical Inc
|
BMRN |
1.34%
|
Iovance Biotherapeutics Inc
|
IOVA |
1.34%
|
Novavax Inc
|
NVAX |
1.32%
|
Aurinia Pharmaceuticals Inc
|
AUPH |
1.31%
|
Tarsus Pharmaceuticals Inc
|
TARS |
1.29%
|
BioNTech SE
|
BNTX |
1.28%
|
Amgen Inc
|
AMGN |
1.28%
|
Theravance Biopharma Inc
|
TBPH |
1.27%
|
United Therapeutics Corp
|
UTHR |
1.26%
|
Biogen Inc
|
BIIB |
1.24%
|
Axsome Therapeutics Inc
|
AXSM |
1.22%
|
Ardelyx Inc
|
ARDX |
1.18%
|
Ionis Pharmaceuticals Inc
|
IONS |
1.09%
|
Legend Biotech Corp
|
LEGN |
0.95%
|
Cash/Cash equivalents
|
Cash.Cash.equivalents |
0.22%
|
OmniAb Inc
|
OmniAb.Inc |
0%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
Virtus LifeSci Biotech Products ETF (BBP) share price today is $100.26.
Yes, Indians can buy shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. To buy BBP from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. You can start investing in Virtus LifeSci Biotech Products ETF (BBP) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Products ETF (BBP) is $105.21. The 52-week low price of Virtus LifeSci Biotech Products ETF (BBP) is $60.91.
The stock symbol (or ticker) of Virtus LifeSci Biotech Products ETF is BBP.
Yes, you can setup SIP in Virtus LifeSci Biotech Products ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBP on the Vested app.
The expense ratio of Virtus LifeSci Biotech Products ETF (BBP) is 0.79%.
Link copied